Device makers may need to change the way they pitch their products as providers make the move to a more stringent focus on value and to more integrated approaches to episodes of care, speakers stressed at the AdvaMed 2009 MedTech conference earlier this month
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Already a subscriber?
The EU is testing a groundbreaking “all-in-one” process for reviewing combined drug and diagnostic trials via a single application for coordinated assessment.
EU countermeasures against US tariffs suggest medtech categories exported to the EU could be targeted for tariffs. MedTech Europe and the German IVDs industry have stressed the negative effects this would have on patient care.
The Development Bank of Wales and London-based Parkwalk Advisors led an investment round of £5m, almost doubling Ceryx Medical's total investment to date.
